XPO1 inhibitor combination therapy with bortezomib or carfilzomib induces nuclear localization of IκBα and overcomes acquired proteasome inhibitor resistance in human multiple myeloma
- 期刊名称Oncotarget
- 作者Turner, Joel G.; Kashyap, Trinayan; Dawson, Jana L.; Gomez, Juan; Bauer, Alexis A.; Grant, Steven; Dai, Yun; Shain, Kenneth H.; Meads, Mark; Landesman, Yosef; Sullivan, Daniel M.
- 卷第7卷
- 期第48期
- 电子ISSN1949-2553
- 文件大小5476.72KB
- 发表时间2016-11-29
- DOI10.18632/oncotarget.12969
Molecular determinants of prostate cancer metastasisRycaj, Kiera; Tang, Dean G. · Oncotarget · 2017
Decellularized scaffolds in regenerative medicineYu, Yaling; Alkhawaji, Ali; Ding, Yuqiang; Mei, Jin · Oncotarget · 2016
Intermittent hypoxia produces Alzheimer disease?Yagishita, Sosuke; Hirasawa, Akira · Oncotarget · 2017
MicroRNAs in lung cancerCastro, Diana; Moreira, Márcia; Gouveia, Alexandra Monteiro; Pozza, Daniel Humberto; De Mello, Ramon Andrade · Oncotarget · 2017
miR-24 in diabetesXiang, Yaozu · Oncotarget · 2015
L1 in tumor vasculatureCavallaro, Ugo · Oncotarget · 2016
Understanding genome structural variationsAbyzov, Alexej; Li, Shantao; Gerstein, Mark B. · Oncotarget · 2016
Value-based genomicsGong, Jun; Pan, Kathy; Fakih, Marwan; Pal, Sumanta; Salgia, Ravi · Oncotarget · 2018